ClinicalTrials.govpublic full text
CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)
mucopolysaccharidosis type ii (mps ii), mps ii, gene therapy, hunter syndrome, lysosomal storage disorder, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 874359
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.